Literature DB >> 6761199

Regulation of serum potassium during insulin-induced hypoglycemia.

K G Petersen, K J Schlüter, L Kerp.   

Abstract

Counterregulatory secretion of epinephrine occurs during severe insulin-induced hypoglycemia. Under these conditions (minimal plasma glucose 27.4 +/- 1 mg/dl) the decrease of serum potassium concentration (0.9 mVal/L) is mediated by two mechanisms: insulin-induced (0.48 mVal/L) and epinephrine-induced (0.42 mVal/L) cellular uptake of potassium. Epinephrine-induced serum potassium uptake appears to be more sensitive to beta-adrenoceptor blockade than glucose production. The intensification of insulin-induced hypokalemia by epinephrine is of clinical significance.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6761199     DOI: 10.2337/diab.31.7.615

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  18 in total

Review 1.  Abnormalities of serum potassium concentration in dialysis-associated hyperglycemia and their correction with insulin: a unique clinical/physiologic exercise in internal potassium balance.

Authors:  Antonios H Tzamaloukas; Todd S Ing; Moses S Elisaf; Dominic S C Raj; Kostas C Siamopoulos; Mark Rohrscheib; Glen H Murata
Journal:  Int Urol Nephrol       Date:  2010-09-19       Impact factor: 2.370

2.  Dynamics of blood electrolytes in repeated hyper- and/or hypoglycaemic events in patients with type 1 diabetes.

Authors:  A Caduff; H U Lutz; L Heinemann; G Di Benedetto; M S Talary; S Theander
Journal:  Diabetologia       Date:  2011-06-15       Impact factor: 10.122

3.  A physiological model of the effect of hypoglycemia on plasma potassium.

Authors:  Toke Folke Christensen; Martin Baekgaard; Jacob Lund Dideriksen; Kristoffer Lindegaard Steimle; Mads Lause Mogensen; Jonas Kildegaard; Johannes Jan Struijk; Ole Kristian Hejlesen
Journal:  J Diabetes Sci Technol       Date:  2009-07-01

4.  Modulation of catecholamine effects during hypoglycaemia in man by urapidil and propranolol.

Authors:  K G Petersen; P Katschker; L Kerp
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

5.  Effect of atenolol on QTc interval lengthening during hypoglycaemia in type 1 diabetes.

Authors:  S P Lee; N D Harris; R T Robinson; C Davies; R Ireland; I A Macdonald; S R Heller
Journal:  Diabetologia       Date:  2005-05-25       Impact factor: 10.122

Review 6.  Diabetes mellitus and electrolyte disorders.

Authors:  George Liamis; Evangelos Liberopoulos; Fotios Barkas; Moses Elisaf
Journal:  World J Clin Cases       Date:  2014-10-16       Impact factor: 1.337

7.  Severe Hypoglycemia and Incidence of QT Interval Prolongation Among Adults With Type 2 Diabetes.

Authors:  Arnaud D Kaze; Matthew F Yuyun; Sebhat Erqou; Gregg C Fonarow; Justin B Echouffo-Tcheugui
Journal:  J Clin Endocrinol Metab       Date:  2022-06-16       Impact factor: 6.134

8.  Haemodynamic changes in insulin-induced hypoglycaemia in normal man.

Authors:  J Hilsted; F Bonde-Petersen; M B Nørgaard; M Greniman; N J Christensen; H H Parving; M Suzuki
Journal:  Diabetologia       Date:  1984-05       Impact factor: 10.122

9.  Adrenaline release evokes hyperpnoea and an increase in ventilatory CO2 sensitivity during hypoglycaemia: a role for the carotid body.

Authors:  Emma L Thompson; Clare J Ray; Andrew P Holmes; Richard L Pye; Christopher N Wyatt; Andrew M Coney; Prem Kumar
Journal:  J Physiol       Date:  2016-05-05       Impact factor: 5.182

10.  Understanding the impact of hypoglycemia on the cardiovascular system.

Authors:  Ian Charles Davis; Ida Ahmadizadeh; Jacqueline Randell; Lisa Younk; Stephen N Davis
Journal:  Expert Rev Endocrinol Metab       Date:  2017-01-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.